125 related articles for article (PubMed ID: 2516692)
21. [Measurement of FDP-D-dimer in DIC and pre-DIC].
Takagi M; Wada H; Tanigawa M; Iwasaki E; Deguchi A; Mori Y; Suzuki H; Ohkubo I; Endou T; Deguchi K
Rinsho Byori; 1990 Jul; 38(7):806-12. PubMed ID: 2205744
[TBL] [Abstract][Full Text] [Related]
22. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
[TBL] [Abstract][Full Text] [Related]
23. Incidence and possible reasons for discordant results between positive FDP and negative D-dimer latex assays in clinical specimens.
Song KS; Kim YA; Kim HK; Park Q
Yonsei Med J; 1999 Apr; 40(2):107-11. PubMed ID: 10333712
[TBL] [Abstract][Full Text] [Related]
24. Pathophysiological response of the blood coagulation system in acute glomerulonephritis.
Alkjaersig NK; Fletcher AP; Lewis ML; Cole BR; Ingelfinger JR; Robson AM
Kidney Int; 1976 Oct; 10(4):319-28. PubMed ID: 994377
[TBL] [Abstract][Full Text] [Related]
25. [Assay of products of fibrin and fibrinogen degradation in disseminated intravascular coagulations. Evaluation of a new technique].
Borschneck C; Dreyfus M; Bridey F; Edouard D; Meyer D
Presse Med; 1995 May 6-13; 24(17):799-802. PubMed ID: 7630868
[TBL] [Abstract][Full Text] [Related]
26. Reactivity of D-dimer assays with the fibrinogen--fibrin split products generated by thrombolytic agents.
Amiral J; Minard F; Plassart V; Vissac AM; Chambrette B
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):525-30. PubMed ID: 2133230
[TBL] [Abstract][Full Text] [Related]
27. High fibrin/fibrinogen degradation product to fibrinogen ratio is associated with 28-day mortality and massive transfusion in severe trauma.
Lee DH; Lee BK; Noh SM; Cho YS
Eur J Trauma Emerg Surg; 2018 Apr; 44(2):291-298. PubMed ID: 28921171
[TBL] [Abstract][Full Text] [Related]
28. [Hemostatic changes before and after the onset of disseminated intravascular coagulation].
Wada H; Tanigawa M; Takagi M; Suzuki H; Mori Y; Ohta T; Kobayashi T; Kita K; Tanaka I; Yamaguchi T
Rinsho Ketsueki; 1989 Oct; 30(10):1755-62. PubMed ID: 2593241
[TBL] [Abstract][Full Text] [Related]
29. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
[TBL] [Abstract][Full Text] [Related]
30. Role of D dimer in patients with elevated fibrinogen degradation products in serum: further study in chronic myelogenous leukemia.
Saito M; Asakura H; Jokaji H; Uotanzi C; Kumabashiri I; Yoshida T; Hashizume K; Matsuda T
Acta Haematol; 1990; 84(3):149-55. PubMed ID: 2123066
[TBL] [Abstract][Full Text] [Related]
31. [Fibrin and fibrinogen degradation products in renal diseases. I. FDP in blood and urine in various stages of clinical glomerulonephritis].
Ratajczak T; Szewczyk Z; Melcer H
Pol Arch Med Wewn; 1977 Nov; 58(5):481-92. PubMed ID: 600826
[No Abstract] [Full Text] [Related]
32. [Studies on the blood coagulation factor XIII in patients with increased levels of FDP D-dimer].
Okumura N; Matsuzawa A; Terasawa F; Kameko M; Sasaki Y; Nakagoshi R; Ishikawa S; Hashikura Y; Matsunami H; Kawasaki S
Rinsho Byori; 1995 Mar; 43(3):269-74. PubMed ID: 7745833
[TBL] [Abstract][Full Text] [Related]
33. [Studies on the fragments of FDP in 4 patients with DIC].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1992 Oct; 40(10):1089-95. PubMed ID: 1307614
[TBL] [Abstract][Full Text] [Related]
34. Hemostatic study before onset of disseminated intravascular coagulation.
Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi A; Mori Y; Deguchi K
Am J Hematol; 1993 Jul; 43(3):190-4. PubMed ID: 8352234
[TBL] [Abstract][Full Text] [Related]
35. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
Kaizu K; Ito Y; Uriu K; Eto S
Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397
[TBL] [Abstract][Full Text] [Related]
37. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of clinical usefulness of a rapid quantitative measurement of D dimer (cross-linked fibrin degradation products)].
Takahashi H; Wada K; Takizawa S; Sakurai G; Hanano M; Niwano H; Tatewaki W; Shibata A
Rinsho Ketsueki; 1991 Dec; 32(12):1533-9. PubMed ID: 1779452
[TBL] [Abstract][Full Text] [Related]
39. Plasma D-dimer levels and their relationship to serum fibrinogen/fibrin degradation products in hypercoagulable states.
Wilde JT; Kitchen S; Kinsey S; Greaves M; Preston FE
Br J Haematol; 1989 Jan; 71(1):65-70. PubMed ID: 2917130
[TBL] [Abstract][Full Text] [Related]
40. [Clinical usefulness of the measurement of plasma D-dimer levels].
Suehiro A; Koyama T
Rinsho Byori; 1991 Jul; 39(7):694-700. PubMed ID: 1920861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
